HK Stock MarketDetailed Quotes

06185 CANSINOBIO

Watchlist
  • 29.350
  • +1.100+3.89%
Market Closed Nov 19 16:08 CST
7.26BMarket Cap-9095P/E (TTM)

CANSINOBIO Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Turnover
222.88%567.08M
1,253.60%285.42M
13.65%114.28M
-66.52%345.18M
-75.17%175.63M
-96.65%21.09M
-79.86%100.55M
-76.02%1.03B
-77.08%707.4M
-69.45%629.79M
Operating income
222.88%567.08M
1,253.60%285.42M
13.65%114.28M
-66.52%345.18M
-75.17%175.63M
-96.65%21.09M
-79.86%100.55M
-76.02%1.03B
-77.08%707.4M
-69.45%629.79M
Cost of sales
----
87.68%-98.27M
----
-0.29%-1.22B
----
-154.31%-797.57M
----
6.17%-1.22B
----
49.85%-313.62M
Operating expenses
15.30%-146.28M
87.68%-98.27M
29.08%-46.23M
-0.29%-1.22B
28.54%-172.72M
-154.31%-797.57M
56.10%-65.19M
6.17%-1.22B
76.91%-241.69M
49.85%-313.62M
Gross profit
14,344.25%420.79M
124.10%187.15M
92.41%68.05M
-369.45%-876.02M
-99.37%2.91M
-345.59%-776.49M
-89.92%35.37M
-106.22%-186.61M
-77.16%465.71M
-77.98%316.17M
Selling expenses
-1.24%-196.04M
12.70%-112.48M
15.27%-46.59M
-32.55%-353.4M
-29.84%-193.63M
-44.93%-128.84M
-60.25%-54.98M
-151.95%-266.61M
-132.61%-149.14M
-157.07%-88.9M
Administrative expenses
37.57%-117.43M
37.33%-87.78M
38.78%-37.07M
-5.89%-294.45M
11.11%-188.09M
-0.30%-140.05M
5.54%-60.55M
-19.95%-278.07M
-49.97%-211.61M
-54.35%-139.63M
Research and development expenses
41.02%-272.27M
45.06%-185.9M
35.40%-96.75M
18.02%-637.99M
15.92%-461.67M
-4.45%-338.37M
4.70%-149.77M
11.43%-778.26M
16.27%-549.07M
41.23%-323.97M
Profit from asset sales
-163.08%-23.63K
----
----
----
--37.46K
----
----
----
----
----
Revaluation surplus
53.23%-7.19M
----
-129.16%-2.09M
----
-379.50%-15.37M
----
56.11%7.17M
----
-82.25%5.5M
----
-Changes in the fair value of other assets
53.23%-7.19M
----
-129.16%-2.09M
----
-379.50%-15.37M
----
56.11%7.17M
----
-82.25%5.5M
----
Impairment and provision
97.02%-23.9M
30.59%-14.06M
-16.94%-15.05M
-71.43%-15.05M
-50.46%-801.12M
-338.13%-20.26M
-108.88%-12.87M
-381.20%-8.78M
-11,281.90%-532.45M
-6,148.65%-4.62M
-Other impairment is provision
97.02%-23.9M
30.59%-14.06M
-16.94%-15.05M
-71.43%-15.05M
-50.46%-801.12M
-338.13%-20.26M
-108.88%-12.87M
-381.20%-8.78M
-11,281.90%-532.45M
-6,148.65%-4.62M
Special items of operating profit
-113.76%-23.02M
-160.73%-37.4M
-230.88%-66.79M
-5.26%141.72M
44.00%167.28M
-19.13%61.58M
31.82%51.03M
16.99%149.58M
204.12%116.16M
78.83%76.15M
Operating profit
84.89%-225.94M
81.34%-250.47M
-6.28%-198.26M
-48.69%-2.04B
-73.96%-1.5B
-714.58%-1.34B
-242.43%-186.54M
-171.60%-1.37B
-169.67%-859.78M
-120.54%-164.8M
Financing income
----
-38.87%54.09M
----
-46.75%120.64M
----
-36.10%88.49M
----
184.45%226.57M
----
235.72%138.49M
Financing cost
-96.12%3.11M
-11.65%-32.82M
502.46%23.38M
-53.82%-64.34M
-62.52%80.29M
-92.87%-29.4M
36.14%-5.81M
23.21%-41.83M
250.27%214.19M
-125.86%-15.24M
Special items of earning before tax
92.94%-2.87M
----
99.98%-1.72K
----
-3,128.89%-40.7M
----
-729.24%-8.12M
----
74.07%-1.26M
----
Earning before tax
84.50%-225.7M
82.14%-229.2M
12.76%-174.88M
-67.14%-1.98B
-125.10%-1.46B
-2,988.28%-1.28B
-265.82%-200.47M
-161.13%-1.18B
-150.13%-646.85M
-104.97%-41.56M
Tax
-228.18%-1.49M
-182.82%-964K
----
-94.78%11.45M
-99.26%1.16M
-97.98%1.16M
558.58%30.27M
838.17%219.24M
263.56%158.17M
-42.57%57.6M
After-tax profit from continuing operations
84.38%-227.2M
82.05%-230.16M
-2.75%-174.88M
-103.93%-1.97B
-197.72%-1.45B
-8,092.09%-1.28B
-248.91%-170.2M
-150.59%-964.76M
-136.64%-488.68M
-98.29%16.04M
Earning after tax
84.38%-227.2M
82.05%-230.16M
-2.75%-174.88M
-103.93%-1.97B
-197.72%-1.45B
-8,092.09%-1.28B
-248.91%-170.2M
-150.59%-964.76M
-136.64%-488.68M
-98.29%16.04M
Minority profit
98.98%-4.79M
98.91%-4.79M
84.38%-4.79M
-776.08%-484.7M
-3,192.65%-469.89M
-11,683.23%-440.74M
-330.62%-30.65M
-657.48%-55.33M
---14.27M
--3.81M
Profit attributable to shareholders
77.42%-222.41M
73.22%-225.37M
-21.89%-170.1M
-63.04%-1.48B
-107.63%-985.03M
-6,975.54%-841.43M
-214.94%-139.55M
-147.51%-909.43M
-135.57%-474.41M
-98.69%12.24M
Basic earnings per share
77.44%-0.9
73.31%-0.91
-21.05%-0.69
-63.32%-6.01
-107.81%-3.99
-6,988.89%-3.41
-216.33%-0.57
-147.55%-3.68
-135.62%-1.92
-98.69%0.0495
Diluted earnings per share
77.44%-0.9
73.31%-0.91
-21.05%-0.69
-63.32%-6.01
-107.81%-3.99
-6,988.89%-3.41
-216.33%-0.57
-147.55%-3.68
-135.62%-1.92
-98.69%0.0495
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
HKAS
CAS (2007)
HKAS
CAS (2007)
HKAS
CAS (2007)
HKAS
CAS (2007)
HKAS
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
--
Auditor
--
--
--
Deloitte Guan Huang Chen Fang Certified Public Accountants, Deloitte Huayong Certified Public Accountants (Special General Partnership)
--
--
--
Deloitte Guan Huang Chen Fang Certified Public Accountants, Deloitte Huayong Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Turnover 222.88%567.08M1,253.60%285.42M13.65%114.28M-66.52%345.18M-75.17%175.63M-96.65%21.09M-79.86%100.55M-76.02%1.03B-77.08%707.4M-69.45%629.79M
Operating income 222.88%567.08M1,253.60%285.42M13.65%114.28M-66.52%345.18M-75.17%175.63M-96.65%21.09M-79.86%100.55M-76.02%1.03B-77.08%707.4M-69.45%629.79M
Cost of sales ----87.68%-98.27M-----0.29%-1.22B-----154.31%-797.57M----6.17%-1.22B----49.85%-313.62M
Operating expenses 15.30%-146.28M87.68%-98.27M29.08%-46.23M-0.29%-1.22B28.54%-172.72M-154.31%-797.57M56.10%-65.19M6.17%-1.22B76.91%-241.69M49.85%-313.62M
Gross profit 14,344.25%420.79M124.10%187.15M92.41%68.05M-369.45%-876.02M-99.37%2.91M-345.59%-776.49M-89.92%35.37M-106.22%-186.61M-77.16%465.71M-77.98%316.17M
Selling expenses -1.24%-196.04M12.70%-112.48M15.27%-46.59M-32.55%-353.4M-29.84%-193.63M-44.93%-128.84M-60.25%-54.98M-151.95%-266.61M-132.61%-149.14M-157.07%-88.9M
Administrative expenses 37.57%-117.43M37.33%-87.78M38.78%-37.07M-5.89%-294.45M11.11%-188.09M-0.30%-140.05M5.54%-60.55M-19.95%-278.07M-49.97%-211.61M-54.35%-139.63M
Research and development expenses 41.02%-272.27M45.06%-185.9M35.40%-96.75M18.02%-637.99M15.92%-461.67M-4.45%-338.37M4.70%-149.77M11.43%-778.26M16.27%-549.07M41.23%-323.97M
Profit from asset sales -163.08%-23.63K--------------37.46K--------------------
Revaluation surplus 53.23%-7.19M-----129.16%-2.09M-----379.50%-15.37M----56.11%7.17M-----82.25%5.5M----
-Changes in the fair value of other assets 53.23%-7.19M-----129.16%-2.09M-----379.50%-15.37M----56.11%7.17M-----82.25%5.5M----
Impairment and provision 97.02%-23.9M30.59%-14.06M-16.94%-15.05M-71.43%-15.05M-50.46%-801.12M-338.13%-20.26M-108.88%-12.87M-381.20%-8.78M-11,281.90%-532.45M-6,148.65%-4.62M
-Other impairment is provision 97.02%-23.9M30.59%-14.06M-16.94%-15.05M-71.43%-15.05M-50.46%-801.12M-338.13%-20.26M-108.88%-12.87M-381.20%-8.78M-11,281.90%-532.45M-6,148.65%-4.62M
Special items of operating profit -113.76%-23.02M-160.73%-37.4M-230.88%-66.79M-5.26%141.72M44.00%167.28M-19.13%61.58M31.82%51.03M16.99%149.58M204.12%116.16M78.83%76.15M
Operating profit 84.89%-225.94M81.34%-250.47M-6.28%-198.26M-48.69%-2.04B-73.96%-1.5B-714.58%-1.34B-242.43%-186.54M-171.60%-1.37B-169.67%-859.78M-120.54%-164.8M
Financing income -----38.87%54.09M-----46.75%120.64M-----36.10%88.49M----184.45%226.57M----235.72%138.49M
Financing cost -96.12%3.11M-11.65%-32.82M502.46%23.38M-53.82%-64.34M-62.52%80.29M-92.87%-29.4M36.14%-5.81M23.21%-41.83M250.27%214.19M-125.86%-15.24M
Special items of earning before tax 92.94%-2.87M----99.98%-1.72K-----3,128.89%-40.7M-----729.24%-8.12M----74.07%-1.26M----
Earning before tax 84.50%-225.7M82.14%-229.2M12.76%-174.88M-67.14%-1.98B-125.10%-1.46B-2,988.28%-1.28B-265.82%-200.47M-161.13%-1.18B-150.13%-646.85M-104.97%-41.56M
Tax -228.18%-1.49M-182.82%-964K-----94.78%11.45M-99.26%1.16M-97.98%1.16M558.58%30.27M838.17%219.24M263.56%158.17M-42.57%57.6M
After-tax profit from continuing operations 84.38%-227.2M82.05%-230.16M-2.75%-174.88M-103.93%-1.97B-197.72%-1.45B-8,092.09%-1.28B-248.91%-170.2M-150.59%-964.76M-136.64%-488.68M-98.29%16.04M
Earning after tax 84.38%-227.2M82.05%-230.16M-2.75%-174.88M-103.93%-1.97B-197.72%-1.45B-8,092.09%-1.28B-248.91%-170.2M-150.59%-964.76M-136.64%-488.68M-98.29%16.04M
Minority profit 98.98%-4.79M98.91%-4.79M84.38%-4.79M-776.08%-484.7M-3,192.65%-469.89M-11,683.23%-440.74M-330.62%-30.65M-657.48%-55.33M---14.27M--3.81M
Profit attributable to shareholders 77.42%-222.41M73.22%-225.37M-21.89%-170.1M-63.04%-1.48B-107.63%-985.03M-6,975.54%-841.43M-214.94%-139.55M-147.51%-909.43M-135.57%-474.41M-98.69%12.24M
Basic earnings per share 77.44%-0.973.31%-0.91-21.05%-0.69-63.32%-6.01-107.81%-3.99-6,988.89%-3.41-216.33%-0.57-147.55%-3.68-135.62%-1.92-98.69%0.0495
Diluted earnings per share 77.44%-0.973.31%-0.91-21.05%-0.69-63.32%-6.01-107.81%-3.99-6,988.89%-3.41-216.33%-0.57-147.55%-3.68-135.62%-1.92-98.69%0.0495
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)HKASCAS (2007)HKASCAS (2007)HKASCAS (2007)HKASCAS (2007)HKAS
Audit Opinions ------Unqualified Opinion------Unqualified Opinion----
Auditor ------Deloitte Guan Huang Chen Fang Certified Public Accountants, Deloitte Huayong Certified Public Accountants (Special General Partnership)------Deloitte Guan Huang Chen Fang Certified Public Accountants, Deloitte Huayong Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data